Alpha Tau Medical Ltd. cotiza a 13.74 USD y tiene una capitalización bursátil de $1.3B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancr…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.50 | $-0.26 | $-0.14 |
| Estimado | $-0.15 | $-0.14 | $-0.12 | $-0.12 |
| Sorpresa | — | -257.1% | -116.7% | -16.7% |
| Métrica | DRTS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -55.3% | -40.4% | -14.9% |
| ROA | -40.4% | -32.0% | -8.3% |
| Current Ratio | 7.45 | 2.84 | +4.61 |
| Debt / Equity | — | 0.28 | — |